Botulinum Toxin Therapy for Spasmodic Dysphonia in Japan: The History and an Update
Spasmodic dysphonia (SD) is a rare neurological disorder that impairs phonatory function by triggering involuntary and intermittent contractions of the intrinsic laryngeal muscles. SD is classified into three types: adductor SD (AdSD), abductor SD (AbSD), and mixed SD. Of these, AdSD accounts for 90...
Main Authors: | Masamitsu Hyodo, Kahori Hirose, Asuka Nagao, Maya Nakahira, Taisuke Kobayashi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/14/7/451 |
Similar Items
-
Botulinum Toxin Therapy: A Series of Clinical Studies on Patients with Spasmodic Dysphonia in Japan
by: Masamitsu Hyodo, et al.
Published: (2021-11-01) -
Post‐treatment clinical course following botulinum toxin injection therapy for adductor spasmodic dysphonia: Analysis of data from a placebo‐controlled, randomized, double‐blinded clinical trial in Japan
by: Kahori Hirose, et al.
Published: (2021-10-01) -
Retrospective review of dosing trends in botulinum toxin injections for the treatment of adductor spasmodic dysphonia in a long-term cohort
by: Gabrielle French, et al.
Published: (2020-01-01) -
Significance of age and sex in botulinum neurotoxin dosing for adductor spasmodic dysphonia
by: Richard Heyes, et al.
Published: (2023-06-01) -
Machine Learning Assessment of Spasmodic Dysphonia Based on Acoustical and Perceptual Parameters
by: Federico Calà, et al.
Published: (2023-03-01)